Intuitive Surgical, Inc. (NASDAQ:ISRG)‘s stock had its “buy” rating restated by equities research analysts at Citigroup Inc. in a report issued on Monday. They presently have a $1,078.00 price objective on the medical equipment provider’s stock, up from their prior price objective of $917.00. Citigroup Inc.’s price target indicates a potential upside of 13.57% from the stock’s previous close.

ISRG has been the topic of a number of other reports. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $911.00 price target on the stock in a research note on Monday, April 24th. Barclays PLC restated a “buy” rating and issued a $800.00 price target on shares of Intuitive Surgical in a research note on Sunday, March 26th. Wedbush lifted their price target on Intuitive Surgical from $835.00 to $875.00 and gave the company an “outperform” rating in a research note on Monday, April 24th. Leerink Swann restated an “outperform” rating on shares of Intuitive Surgical in a research note on Wednesday, July 5th. Finally, Morgan Stanley set a $950.00 price target on Intuitive Surgical and gave the company an “overweight” rating in a research note on Monday, May 22nd. Seven research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company’s stock. Intuitive Surgical currently has a consensus rating of “Buy” and a consensus target price of $963.44.

Shares of Intuitive Surgical (ISRG) traded up 2.34% on Monday, hitting $949.17. The stock had a trading volume of 501,164 shares. The firm has a 50 day moving average of $934.93 and a 200 day moving average of $803.42. Intuitive Surgical has a 12 month low of $610.71 and a 12 month high of $974.66. The stock has a market cap of $35.26 billion, a P/E ratio of 45.46 and a beta of 0.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $5.79 by $0.16. The business had revenue of $756.20 million for the quarter, compared to analyst estimates of $724.51 million. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The company’s revenue for the quarter was up 12.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.62 earnings per share. On average, equities analysts forecast that Intuitive Surgical will post $23.86 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This story was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another domain, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/07/24/intuitive-surgicals-nasdaqisrg-buy-rating-reaffirmed-at-citigroup-inc.html.

In other news, Director Amal M. Johnson sold 1,000 shares of the company’s stock in a transaction on Wednesday, May 31st. The stock was sold at an average price of $917.27, for a total value of $917,270.00. Following the sale, the director now directly owns 3,787 shares in the company, valued at $3,473,701.49. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Jamie Samath sold 48 shares of the company’s stock in a transaction on Friday, May 5th. The shares were sold at an average price of $850.00, for a total value of $40,800.00. The disclosure for this sale can be found here. Insiders sold 26,655 shares of company stock worth $23,366,682 over the last 90 days. Company insiders own 2.50% of the company’s stock.

Several hedge funds have recently modified their holdings of ISRG. Guardian Life Insurance Co. of America increased its stake in shares of Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 3 shares in the last quarter. Greenleaf Trust increased its stake in shares of Intuitive Surgical by 0.8% in the first quarter. Greenleaf Trust now owns 477 shares of the medical equipment provider’s stock valued at $366,000 after buying an additional 4 shares in the last quarter. Dynamic Advisors Solutions LLC increased its stake in shares of Intuitive Surgical by 0.6% in the first quarter. Dynamic Advisors Solutions LLC now owns 905 shares of the medical equipment provider’s stock valued at $694,000 after buying an additional 5 shares in the last quarter. Bronfman E.L. Rothschild L.P. increased its stake in shares of Intuitive Surgical by 1.8% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 280 shares of the medical equipment provider’s stock valued at $215,000 after buying an additional 5 shares in the last quarter. Finally, Miles Capital Inc. increased its stake in shares of Intuitive Surgical by 1.3% in the first quarter. Miles Capital Inc. now owns 566 shares of the medical equipment provider’s stock valued at $434,000 after buying an additional 7 shares in the last quarter. Institutional investors and hedge funds own 97.56% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.